In vitro and in vivo activity of antimicrobial peptides synthesized based on the insect defensin

Peptides

Volumn 25, Issue 1, 2004, Pages 19-27

  Saido Sakanaka, Hisako ^a   Ishibashi, Jun ^a   Momotani, Eiichi ^b   Amano, Fumio ^c   Yamakawa, Minoru ^a,d  

^a NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Antimicrobial peptide; Chemical synthesis; Insect defensin; MRSA; TNF

Indexed keywords

AMINO ACID DERIVATIVE; ANTIINFECTIVE AGENT; DEFENSIN; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; METICILLIN; PEPTIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; FIBROBLAST; GENE; GENE EXPRESSION; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; INSECT; LETHALITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; PROVOCATION TEST; TUMOR NECROSIS ALPHA GENE;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; CYTOTOXINS; DEFENSINS; GENE EXPRESSION; HEMOLYSIN PROTEINS; INSECT PROTEINS; MALE; MICE; MICE, INBRED C57BL; PEPTIDES; RABBITS; TUMOR NECROSIS FACTOR-ALPHA;

FUNGI; INSECTA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MURINAE; ORYCTOLAGUS CUNICULUS; STAPHYLOCOCCUS AUREUS;

EID: 1542315480     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2003.12.009     Document Type: Article

References (42)

1. Alvarez-Bravo J., Kurata S., Natori S. Novel synthetic antimicrobial peptides effective against methicillin-resistant Staphylococcus aureus. Biochem. J. 302:1994;535-538.
2. Blondelle S.E., Houghton R.A. Hemolytic and antimicrobial activities of the twenty-four individual omission analogues of mellitin. Biochemistry. 30:1991;4671-4678.
3. Boman H.G. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 13:1995;61-92.
4. Fauchere J., Pliska V. Hydrophobic parameters π of amino-acid side chains from the partitioning of N-acetyl-amino-acid amides. Eur. J. Med. Chem. 18:1983;369-375.
5. Fernandez-Lopez S., Kim H.S., Choi E.C., Delgado M., Granj J.R., Khasanov A.et al. Antibacterial agents based on the cyclic D,L-α-peptide architecture. Nature. 412:2001;452-455.
6. Fischer W., Mannsfeld T., Hagen G. On the basic structure of poly(glycerophosphate) lipoteichoic acids. Biochem. Cell. Biol. 68:1990;33-43.
7. Friedman G., Silva E., Vincent J.T. Has the mortality of septic shock changed with time? Care Med. 26:1998;2078-2086.
8. Friedrich C.L., Moyles D., Beveridge T.J., Hancock R.E.W. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria, second structure study. Antimicrob. Agents Chemother. 44:2000;2086-2092.
9. Friedrich C.L., Rozek A., Patrzykat A., Hancock R.E.W. Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacterial. J. Biol. Chem. 276:2001;24015-24022.
10. Gough M., Hancock R.E.W., Kelly N.M. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect. Immun. 64:1996;4922-4927.
11. Hancock R.E.W. Peptide antibiotic. Lancet. 349:1997;418-422.
12. Hancock R.E.W., Falla T., Brown M. Cationic bactericidal peptides. Adv. Microb. Physiol. 37:1997;135-175.
13. Hara S., Asaoka A., Yamakawa M. Effect of moricin, a novel antibacterial peptide of Bombyx mori (Lepidoptera Bombycidae) on the growth of methicillin-resistant Staphylococcus aureus (MRSA). Appl. Entomol. Zool. 31:1996;465-466.
14. Hirata M., Shimomura Y., Yoshida M., Morgan J.G., Palings I., Wilson D. et al. Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Infect. Immun. 62:1994;1421-1426.
15. Hoek K.S., Milen J.M., Grieve P.A., Donysius D.A., Smith R. Antibacterial activity of bovine lactofferin-derived peptides. Antimicrob. Agents Chemother. 41:1997;54-59.
16. Ishibashi J., Saido-Sakanaka H., Yang J., Sagisaka A., Yamakawa M. Purification, cDNA cloning and modification of a defensin from the coconut rhinoceros beetle, Oryctes rhinoceros. Eur. J. Biochem. 266:1999;1-9.
17. Jack R.W., Tagg J.R., Ray B. Bacteriocin of gram positive bacteria. Microbiol. Rev. 59:1995;171-200.
18. Kustanovich I., Shalev D.E., Mikhlin M., Gaidukov L., Mor A. Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives. J. Biol. Chem. 277:2002;16941-16951.
19. Lee D.G., Kim H.N., Park Y., Kim H.K., Choi B.H., Choi C.H.et al. Design of novel analogue peptides with potent antibiotic activity based on the antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1. Biochim. Biophys. Acta. 1598:2002;185-194.
20. Lee D.G., Kim P.I., Park Y., Woo E.R., Choi J.S., Choi C.H.et al. Design of novel peptide analogs with potent fungicidal activity, based on PMAP-23 antimicrobial peptide isolated from porcine myeloid. Biochem. Biophys. Res. Commun. 298:2002;231-238.
21. Lee K.H., Hong S.Y., Oh J.E., Kwon M.Y., Yoon J.H., Lee J.H.et al. Identification and characterization of the antimicrobial peptide corresponding to C-terminal β-sheet domain of tenecin 1, an antibacterial protein of larvae of Tenebrio molitor. Biochem. J. 334:1998;99-105.
22. Miyanoshita A., Hara S., Sugiyama M., Asaoka A., Taniai K., Yukuhiro F. et al. Isolation and characterization of new member of insect defensin family from a beetle, Allomyrina dichotoma. Biochem. Biophys. Res. Commun. 220:1996;526-531.
23. + cells. J. Immunol. 167:2001;3329-3338.
24. Nakajima Y., Alvarrez-Bravo J., Cho J.H., Homma K., Kanegasaki S., Natori S. Chemotherapeutic activity of synthetic antimicrobial peptides: correlation between chemotherapeutic activity and neutrophil-activating activity. FEBS Lett. 415:1997;64-66.
25. Opel S.M., Cohen J. Clinical gram-positive sepsis: does it fundamentally differ from gram-negative sepsis? Crit. Care Med. 27:1999;1608-1616.
26. Pachner A.R., Dail D., Li L., Gurey L., Feng S., Hodzic E.et al. Humoral immune response associated with lyme borreliosis in nonhuman primates: analysis by immunoblotting and enzymelinked immunosorbent assay with sanicates or recombinant proteins. Clin. Diagn. Lab. Immunol. 9:2002;1348-1355.
27. Putsep K., Normark S., Boman H.G. The origin of cecropins, implication from synthetic peptides derived from ribosomal protein L1. FEBS Lett. 451:1999;249-252.
28. Rasmussen K.R., Healey M.C. Experimental Cryptosporidium parvum infections in immunosuppressed adult mice. Infect. Immun. 60:1992;1648-1652.
29. Rothstein D.M., Spacciapoli P., Tran L.T., Xu T., Roberts F.D., Dalla Serra M.et al. Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5. Antimicrob. Agents Chemother. 45:2001;1367-1373.
30. Saido-Sakanaka H., Ishibashi J., Sagisaka A., Momotani E., Yamakawa M. Synthesis and characterization of bactericidal oligopeptides designed on the bases of an insect antibacterial peptide. Biochem. J. 338:1999;29-33.
31. Sawa T., Kurahashi K., Ohara M., Gropper M.A., Doshi V., Larrick J.W.et al. Evaluation of antimicrobial and lipopolysacchride-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model. Antimicrob. Agents Chemother. 42:1998;3269-3575.
32. Scott M.G., Gold M.R., Hancock R.E.W. Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria. Infect. Immun. 67:1999;6445-6453.
33. Scott M.G., Vreugdenhil A.C., Bourman W.A., Hancock R.E.W., Gold M.R. Cutting edge: cationic antibacterial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J. Immunol. 164:2000;549-553.
34. Seydel U., Schromm A.B., Blunck R., Brandenberg K. Chemical structure, molecular conformation, and bioactivity of endotoxins. Chem. Immunol. 74:2000;5-24.
35. Shin S.Y., Kang J.H., Lee M.K., Kim S.Y., Kim Y., Hahm K.S. Cecropin A-magainin 2-hybrid peptides having potent antimicrobial activity with low hemolytic effect. Biochem. Mol. Biol Int. 44:1998;1119-1126.
36. Sriskandan S., Cohen J. Gram-positive sepsis mechanisms and differences from gram-negative sepsis. Infect. Dis. Clin. N. Am. 13:1999;397-412.
37. Steinberg D.A., Hurst M.A., Fujii C.A., Kung A.H.C., Ho J.F., Cheng F.C.et al. Protegrin-l: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob. Agents Chemother. 41:1997;1738-1742.
38. Subbalakshmi V., Krishnakmari V., Nagaraj R., Sitaram N. Requirements for antibacterial and hemolytic activities in the bovine neutrophil derived 13-residue peptide indolicidin. FEBS Lett. 395:1996;48-52.
39. Verkleij A.J., Zwaal R.F.A., Roelofsen B., Comfurius P., Kastelijn D., van Deenen L.L.M. The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholipases and freeze-etch electron microscopy. Biochim. Biophys. Acta. 323:1973;178-193.
40. Yamada K., Natori S. Purification, sequence and antibacterial activity of two novel sapecin homologues from sacrophaga embryonic cells: similarity of sapecin B to charybdotoxin. Biochim. J. 291:1993;275-279.
41. Yamada K., Natori S. Characterization of the antimicrobial peptide derived from sapecin B, an antibacterial protein of Sarcophaga peregrina (flesh fly). Biochim. J. 298:1994;623-628.
42. Zhang O.H., Mann D.M., Tsai C.M. Neutralization of endotoxin in vitro and in vivo by human lactoferrin-derived peptide. Infect. Immun. 67:1999;1353-1358.